Biopharmaceutical company Pfizer seeks emergency use authorisation for its COVID-19 vaccine in India

Biopharmaceutical company Pfizer seeks emergency use authorisation for its COVID-19 vaccine in India

Pfizer, has sought emergency use authorisation for its COVID-19 vaccine in India. The firm, in its application submitted to the drug regulator, has sought permission to import the vaccine for sale and distribution in the country. With this, Pfizer India has become the first pharmaceutical firm to seek from the Drugs Controller General of India (DCGI) an emergency use authorisation for its COVID-19 vaccine in the country, after its parent company secured such clearance in the UK and Bahrain.

also read CPCB raises concern on pollution and frothing in Yamuna River

also read Telangana: TRS won 55 seats in GHMC polls and emerges as single largest party